We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
(+2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Best Buy
BBY
|
+$2.79M |
| 2 |
Bath & Body Works
BBWI
|
+$2.78M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.7M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
ExxonMobil
XOM
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.99M |
| 3 |
ORPH
Orphazyme A/S
ORPH
|
+$5.06M |
| 4 |
BridgeBio Pharma
BBIO
|
+$3.35M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Technology | 16.03% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 13.91% |
| 5 | Financials | 11.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRC
826
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $258K | 0.04% |
+6,435
| New | +$232K |
|
827
iShares Expanded Tech Sector ETF
IGM
$10.8B
| $257K | 0.04% |
+4,416
| New | +$242K |
|
828
Lifecore Biomedical
LFCR
$190M
| $256K | 0.04% |
23,606
-24,333
| -51% | -$251K |
|
829
OraSure Technologies
OSUR
$279M
| $256K | 0.04% |
+24,221
| New | +$318K |
|
830
Virgin Galactic
SPCE
$398M
| $256K | 0.04% |
+539
| New | +$252K |
|
|
ORBC
831
DELISTED
ORBCOMM, Inc.
ORBC
| $256K | 0.04% |
34,446
-91,384
| -73% | -$493K |
|
832
Boston Properties
BXP
$11.1B
| $255K | 0.04% |
+2,702
| New | +$241K |
|
833
Beyond Meat
BYND
$277M
| $255K | 0.04% |
+2,040
| New | +$308K |
|
834
Invesco Mortgage Capital
IVR
$805M
| $255K | 0.04% |
7,542
+2,914
| +63% | +$90.2K |
|
835
Kinder Morgan
KMI
$68.7B
| $255K | 0.04% |
18,650
-23,104
| -55% | -$309K |
|
|
BBBY
836
Bed Bath & Beyond
BBBY
$442M
| $253K | 0.04% |
+5,801
| New | +$343K |
|
837
Lipocine
LPCN
$17.6M
| $253K | 0.04% |
10,941
+6,246
| +133% | +$150K |
|
838
Talphera
TLPH
$74.2M
| $253K | 0.04% |
10,192
+2,283
| +29% | +$69.8K |
|
839
XPO
XPO
$23.7B
| $253K | 0.04% |
+6,130
| New | +$222K |
|
840
Evolent Health
EVH
$447M
| $252K | 0.04% |
15,690
-75,210
| -83% | -$994K |
|
841
i3 Verticals
IIIV
$342M
| $252K | 0.04% |
7,597
-4,950
| -39% | -$133K |
|
842
Standard BioTools
LAB
$314M
| $252K | 0.04% |
41,944
-40,959
| -49% | -$269K |
|
|
WSR
843
DELISTED
Whitestone REIT
WSR
| $252K | 0.04% |
+31,628
| New | +$227K |
|
844
Bankunited
BKU
$3.36B
| $251K | 0.04% |
+7,221
| New | +$206K |
|
845
Eversource Energy
ES
$27.2B
| $251K | 0.04% |
+2,900
| New | +$258K |
|
846
Ameren
AEE
$30.1B
| $250K | 0.04% |
+3,200
| New | +$256K |
|
|
DMK
847
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $250K | 0.04% |
7,374
+6,578
| +826% | +$293K |
|
|
MTSC
848
DELISTED
MTS Systems Corp
MTSC
| $250K | 0.04% |
+4,300
| New | +$155K |
|
849
CorVel
CRVL
$3.19B
| $248K | 0.04% |
+7,008
| New | +$218K |
|
850
Harvard Bioscience
HBIO
$29.2M
| $248K | 0.04% |
5,788
+1,030
| +22% | +$38.4K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.
- GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
- GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
- GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
- GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
- GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
- GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
- GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.
Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.